Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III open-label study of AMW Leuprorelin 10.72 mg implant in prostate cancer
2011-006014-14Phase 3Completed
- Sponsor
- AMW GmbH
- Start
- Feb 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by AMW GmbH. Started Feb 2012; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2011-006014-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006014-14.